论文信息 - Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study. - 字舞流文

Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.

K. Chow | P. Li | C. Szeto | S. Mak | C. Leung | Yuk-lun Cheng | A. Yu | S. Fung | T. Wong | A. Tang | C. Yung | J. Yung